GO:0051246 regulation of protein metabolic process: Protein Homeostasis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051246 regulation of protein metabolic process describes any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein.
• This term is a broad biological_process node that encompasses regulation of protein synthesis, folding, modification, transport, and degradation.
• E3 ubiquitin ligase complexes are central regulators of protein metabolic processes by targeting metabolic enzymes for proteasomal degradation.
• Dysregulation of protein metabolic process regulation is implicated in cancer, metabolic disorders, and neurodegeneration.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal dissection of regulatory nodes within this process.
• Targeted protein degradation technologies such as PROTACs therapeutically exploit the regulation of protein metabolic process.
Description
The Gene Ontology (GO) term GO:0051246, regulation of protein metabolic process, is defined as any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein. This broad biological_process term captures the regulatory layers that control protein synthesis, post-translational modification, folding, transport, and degradation, which together determine protein abundance and function within cells. Understanding this term is essential because protein metabolic processes are not static; they are dynamically adjusted in response to nutrients, stress, and developmental cues. For researchers, GO:0051246 provides a conceptual framework to annotate and interpret how cells maintain proteostasis and how its disruption contributes to disease. The regulation of protein metabolic process intersects with nearly every cellular pathway, from metabolic enzyme turnover to signal transduction. Consequently, experimental models that perturb specific regulators within this process are critical for uncovering causal mechanisms and therapeutic targets.
regulation of protein metabolic process At A Glance
| GO ID | GO:0051246 |
|---|---|
| GO term | regulation of protein metabolic process |
| Ontology | biological_process |
| Synonym | regulation of cellular protein metabolic process; regulation of cellular protein metabolism; regulation of protein metabolism |
| Definition | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein. |
| Major function | Regulation of protein synthesis, modification, folding, transport, and degradation to maintain proteostasis. |
| Related processes | Protein ubiquitination, proteasomal degradation, autophagy, translation regulation, post-translational modification. |
| Example regulators | E3 ubiquitin ligases, deubiquitinases, kinases, phosphatases, chaperones, proteasome components. |
| Disease relevance | Cancer, metabolic disorders, neurodegeneration, and developmental defects. |
What Is GO:0051246?
In our own words, GO:0051246 regulation of protein metabolic process refers to any biological process that controls the rate, frequency, or extent of the chemical reactions and pathways that build, modify, transport, or break down proteins. It is a parent term that includes regulation of protein biosynthesis, protein modification, protein folding, protein transport, and protein catabolism. The term is used in GO annotation to group gene products that modulate protein metabolism rather than directly performing the metabolic reactions themselves.
Why Is regulation of protein metabolic process Important in Cell Biology?
Regulation of protein metabolic process is fundamental to cellular homeostasis because it determines the abundance, localization, and activity of essentially every protein. Disruption of this regulation leads to accumulation of damaged proteins or loss of critical enzymes, contributing to diseases such as cancer and neurodegeneration. Moreover, therapeutic strategies including PROTACs deliberately hijack protein degradation pathways to eliminate disease-causing proteins.
• Maintains proteostasis by balancing protein synthesis and degradation.
• Controls metabolic enzyme levels in response to nutrients and stress.
• Regulates cell cycle progression and differentiation through targeted protein turnover.
• Dysregulation is linked to cancer, where oncoproteins or tumor suppressors are aberrantly stabilized or degraded.
• Neurodegenerative diseases often involve impaired clearance of aggregation-prone proteins.
• Provides targets for therapeutic intervention via PROTACs and molecular glues.
• Essential for immune response and inflammation through regulated cytokine production.
• Impacts stem cell self-renewal and differentiation via metabolic regulation.
• Influences drug sensitivity by altering levels of drug targets or resistance factors.
• Enables cellular adaptation to environmental stress such as salt stress in plants.
What Happens During regulation of protein metabolic process?
Regulation of protein synthesis
In simple terms: Cells control how much protein is made from mRNA.
Regulation of protein synthesis involves modulating translation initiation, elongation, and termination. This layer of control determines the rate at which proteins are produced and is responsive to nutrients, growth factors, and stress. Key regulators include mTOR signaling and translation initiation factors. Dysregulation can lead to overproduction of oncoproteins or insufficient production of tumor suppressors.
Regulation of protein folding and modification
In simple terms: After being made, proteins must fold correctly and receive chemical tags to function.
Post-translational modifications such as phosphorylation, ubiquitination, and S-glutathionylation alter protein stability and activity. Chaperones assist folding, and modification enzymes add or remove chemical groups. For example, S-glutathionylation confers cellular resistance to ferroptosis induced by glutathione depletion. These modifications are reversible and tightly regulated.
Regulation of protein transport and localization
In simple terms: Proteins must be delivered to the right place in the cell.
Proteins are actively transported between cellular compartments, such as from the endoplasmic reticulum to the Golgi and then to their final destinations. GLUT4 exocytosis is a classic example where insulin regulates the translocation of glucose transporters to the plasma membrane, thereby controlling glucose uptake. This process is critical for metabolic regulation.
Regulation of protein degradation
In simple terms: Cells tag unwanted or damaged proteins for destruction.
The ubiquitin-proteasome system and autophagy are the major routes for protein degradation. E3 ubiquitin ligases recognize specific substrates and attach ubiquitin chains, marking them for proteasomal degradation. Proteolytic regulation of metabolic enzymes by E3 ubiquitin ligase complexes is well illustrated in yeast. This degradation controls enzyme levels and eliminates misfolded proteins.
Integration of regulatory signals
In simple terms: Multiple signals are combined to fine-tune protein metabolism.
Signaling pathways such as insulin/IGF-1, mTOR, and stress-responsive kinases integrate to coordinate protein synthesis and degradation. Forkhead Box O (FOXO) transcription factors are key integrators that regulate genes involved in protein turnover, oxidative stress resistance, and metabolism. This integration ensures that protein metabolic processes adapt to changing physiological states.
Key Genes Involved in GO:0051246 regulation of protein metabolic process
The following genes and proteins are representative regulators or components of the regulation of protein metabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UBB | Ubiquitin precursor | Central to ubiquitin-proteasome degradation |
| UBC | Ubiquitin conjugating enzyme | Polyubiquitin chain formation |
| PSMD1 | Proteasome 26S subunit | Proteasomal degradation of proteins |
| FOXO1 | Transcription factor | Regulates genes in protein turnover and metabolism |
| FOXO3 | Transcription factor | Stress resistance and autophagy regulation |
| MTOR | Kinase | Master regulator of protein synthesis |
| RPTOR | mTOR complex component | Nutrient sensing and translation control |
| EIF4E | Translation initiation factor | Cap-dependent translation regulation |
| SLC2A4 (GLUT4) | Glucose transporter | Insulin-regulated exocytosis |
| CDK8 | Cyclin-dependent kinase | Regulates salt tolerance via protein modification |
| AHL10 | Plant-specific protein | CDK8 substrate in stress response |
| SUVH2 | Histone methyltransferase | Chromatin regulation linked to stress |
| SUVH9 | Histone methyltransferase | Chromatin regulation linked to stress |
| SMN1 | Survival motor neuron protein | RNA splicing and protein metabolism; target of risdiplam |
| SMN2 | Survival motor neuron protein 2 | Modifier of SMA; risdiplam enhances SMN2 splicing |
| CRBN | E3 ligase substrate receptor | Target for PROTACs |
| VHL | E3 ligase substrate receptor | Target for PROTACs |
How Is regulation of protein metabolic process Regulated?
Regulation of protein metabolic process is itself regulated at multiple levels. The mTOR pathway senses amino acids and growth factors to promote protein synthesis while inhibiting autophagy. FOXO transcription factors are inhibited by insulin/IGF-1 signaling and activate genes for protein degradation and stress resistance when nutrients are scarce. In plants, the CDK8-AHL10-SUVH2/9 module dynamically regulates salt tolerance by modulating protein function and gene expression. Additionally, S-glutathionylation of proteins can alter their activity and stability in response to oxidative stress. These regulatory mechanisms ensure that protein metabolism adapts to environmental and developmental cues.
regulation of protein metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SMN1 | Spinal muscular atrophy | Knockout of SMN1 in motor neurons; SMN2 splicing reporters |
| FOXO1 | Cancer, diabetes | Knockout and overexpression in cancer cell lines |
| MTOR | Cancer, metabolic disorders | Point mutation of kinase domain; knockout |
| CRBN | Cancer, multiple myeloma | Knockout to study PROTAC sensitivity |
| SLC2A4 | Type 2 diabetes | Knockout in adipocytes; tagged knock-in for imaging |
Cancer
Dysregulation of protein metabolic process is a hallmark of cancer. Overexpression of E3 ligases or loss of tumor suppressors can lead to aberrant degradation of cell cycle inhibitors or stabilization of oncoproteins. Targeting protein degradation pathways with PROTACs offers a novel therapeutic strategy to eliminate cancer-driving proteins.
Neurodegenerative diseases
Impaired protein degradation contributes to the accumulation of toxic protein aggregates in neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. Enhancing clearance mechanisms or modulating ubiquitin-proteasome activity is a potential therapeutic approach.
Spinal muscular atrophy (SMA)
SMA is caused by loss of SMN1, leading to insufficient SMN protein. Risdiplam, a small molecule that modifies SMN2 pre-mRNA splicing to increase functional SMN protein, exemplifies therapeutic regulation of protein metabolic process at the RNA level.
Metabolic disorders
Altered regulation of protein metabolism in metabolic tissues contributes to insulin resistance and diabetes. For example, GLUT4 exocytosis is impaired in insulin-resistant states, affecting glucose homeostasis. Modulating protein turnover of metabolic enzymes may provide therapeutic benefits.
From regulation of protein metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of E3 ligase X alter substrate stability? | Knockout cell line |
| Does a point mutation in a phosphorylation site affect protein turnover? | Point mutation knock-in |
| How does a disease-associated mutation affect protein function? | Knock-in of mutant allele |
| Where is the protein localized under stress? | Tagged knock-in (e.g., GFP) |
| Does overexpression of a regulator drive oncogenesis? | Overexpression cell model |
| Which genes regulate protein metabolism in a genome-wide manner? | CRISPR library screening |
How to Study the regulation of protein metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| SILAC | Protein synthesis and degradation rates | Global protein turnover |
| Ribo-seq | Translated mRNA fragments | Translation efficiency |
| RNA-seq | mRNA abundance | Transcriptional regulation |
| Proteomics (LC-MS/MS) | Protein abundance and modifications | Post-translational modifications |
| Fluorescence microscopy | Protein localization and dynamics | GLUT4 exocytosis |
| CRISPR knockout screen | Gene function loss | Identify regulators of protein stability |
| CRISPR activation screen | Gene overexpression | Identify enhancers of degradation |
| Proximity labeling (BioID) | Protein-protein interactions | Map E3 ligase substrates |
Proteomics and protein turnover assays
Mass spectrometry-based proteomics can quantify global protein abundance and identify changes in response to perturbations. Stable isotope labeling with amino acids in cell culture (SILAC) or pulsed SILAC measures protein synthesis and degradation rates. These methods are essential to study regulation of protein metabolic process.
Transcriptomics and translatomics
RNA-seq measures mRNA levels, while ribosome profiling (Ribo-seq) captures actively translated mRNAs. These techniques reveal how regulation of protein synthesis is controlled at the translational level.
Imaging and localization
Fluorescence microscopy of tagged proteins (e.g., GFP knock-in) allows real-time tracking of protein localization and trafficking. This is particularly useful for studying processes like GLUT4 exocytosis.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify regulators of protein metabolic process. These screens link genes to phenotypes such as protein stability or drug resistance.
How CRISPR Can Be Used to Study GO:0051246 regulation of protein metabolic process
Knockout
CRISPR knockout generates loss-of-function alleles by introducing frameshift mutations. This is used to study the role of E3 ligases, kinases, or proteasome subunits in protein metabolic process. For example, knocking out CRBN can reveal its role in PROTAC-mediated degradation.
Point Mutation
CRISPR point mutation introduces specific amino acid changes to dissect catalytic activity, phosphorylation sites, or ubiquitination sites. This helps determine whether a specific modification regulates protein stability or function.
Knock-in
Knock-in of tagged proteins (e.g., GFP, HA) or disease-associated alleles allows tracking of protein localization and turnover. Knock-in of mutant SMN2 or other disease genes can model human disorders.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression enables gain-of-function studies. Overexpressing a regulator can test whether it is sufficient to drive changes in protein metabolism, such as oncogenic transformation.
How EDITGENE Supports regulation of protein metabolic process Research
Researchers studying regulation of protein metabolic process-related genes often need to determine whether a candidate gene is causally involved in a specific step of protein synthesis, modification, or degradation. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of protein metabolic process research.
Frequently Asked Questions About regulation of protein metabolic process
What is GO:0051246 regulation of protein metabolic process?
GO:0051246 is a Gene Ontology biological_process term defined as any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein.
What genes are involved in regulation of protein metabolic process?
Key genes include E3 ubiquitin ligases (e.g., CRBN, VHL), proteasome subunits (e.g., PSMD1), mTOR, FOXO transcription factors, and translation initiation factors.
How is protein metabolic process regulated?
It is regulated at multiple levels, including transcription, translation, post-translational modifications, and degradation via the ubiquitin-proteasome system and autophagy.
What diseases are associated with dysregulation of protein metabolic process?
Cancer, neurodegenerative diseases, spinal muscular atrophy, and metabolic disorders such as diabetes.
What is the role of ubiquitination in protein metabolic process?
Ubiquitination tags proteins for proteasomal degradation, thereby controlling their abundance and activity.
How can CRISPR be used to study regulation of protein metabolic process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes involved in protein synthesis, modification, and degradation.
What is the difference between regulation of protein metabolic process and protein metabolism?
Protein metabolism refers to the chemical reactions themselves, while regulation of protein metabolic process refers to processes that modulate those reactions.
Which experimental methods are used to study protein metabolic process?
Proteomics, Ribo-seq, RNA-seq, imaging, and CRISPR screens are commonly used.
What is the connection between mTOR and protein metabolic process?
mTOR is a master regulator that promotes protein synthesis and inhibits degradation in response to nutrients and growth factors.
How does S-glutathionylation affect protein metabolic process?
S-glutathionylation is a post-translational modification that can alter protein function and confer resistance to ferroptosis.
Conclusion
GO:0051246 regulation of protein metabolic process is a broad yet fundamental biological process that controls the life cycle of proteins. Its dysregulation underlies numerous diseases, making it a rich area for therapeutic intervention. CRISPR-based models and advanced omics technologies continue to unravel the complex regulatory networks involved, offering new opportunities for drug discovery and precision medicine.
References
- 1. Shinwari ZK et al.. 2018. Ethical Issues Regarding CRISPR Mediated Genome Editing.. Curr Issues Mol Biol 26:103-110 PMID: 28879860
- 2. Guo P et al.. 2025. Salt stress activates the CDK8-AHL10-SUVH2/9 module to dynamically regulate salt tolerance in Arabidopsis.. Nat Commun 16(1):2454 PMID: 40074748
- 3. Ju Y et al.. 2025. Protein S-glutathionylation confers cellular resistance to ferroptosis induced by glutathione depletion.. Redox Biol 83:103660 PMID: 40354766
- 4. Dhillon S. 2020. Risdiplam: First Approval.. Drugs 80(17):1853-1858 PMID: 33044711
- 5. Stöckli J et al.. 2011. GLUT4 exocytosis.. J Cell Sci 124(Pt 24):4147-59 PMID: 22247191
- 6. Ludikhuize MC et al.. 2021. Metabolic Regulation of Stem Cells and Differentiation: A Forkhead Box O Transcription Factor Perspective.. Antioxid Redox Signal 34(13):1004-1024 PMID: 32847377
- 7. Nakatsukasa K et al.. 2015. Proteolytic regulation of metabolic enzymes by E3 ubiquitin ligase complexes: lessons from yeast.. Crit Rev Biochem Mol Biol 50(6):489-502 PMID: 26362128
- 8. Benowitz AB et al.. 2021. The therapeutic potential of PROTACs.. Expert Opin Ther Pat 31(1):1-24 PMID: 33081540
